CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We raise our target by $90 to $1,090, using a forward P/E of 16.5x our 2027 earnings estimate compared to the three-year historical average at 14.1x. We keep our EPS estimates at $62.00 in 2026 and $66.00 in 2027, near consensus, which may undergo upward estimate revisions should we see an active IPO market over the rest of this year. Several of the mega-IPOs, such as SpaceX, are represented by GS as a lead underwriter. Markets that include equity trading continue to benefit from rising prices and market volatility. A secondary positive effect is higher fee income in the Asset & Wealth Management segment. We believe investment banking fees will also see higher transactions that boost M&A advisory fees and related financing. In late June, GS and other Global Systemically Important Banks (G-SIB) will receive the Fed's annual stress test results that direct their return of capital. Subsequently, we expect GS to authorize higher authorized share repurchases and dividend hikes that support our Buy rating.